Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fampridine with Motor Training in MS
NCT02146534Phase 4Completed
- Sponsor
- Clinique Neuro-Outaouais
- Start
- Dec 2013
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in multiple sclerosis (MS) comparing Fampridine Arm with Placebo Arm (2 arms). Primary endpoint: Incidence of responders, degree of response, and duration of response in mobility at 14 weeks. Started Dec 2013; status: completed.
02
Drugs
dalfampridine
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT02146534.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02146534.